Sea anemones venom key to Multiple Sclerosis treatment

July 23, 2012 in Immunology

Sea anemones venom key to Multiple Sclerosis treatment

Enlarge

The purple sea anemone awaits passing prey, which it stings with its venom-filled tentacles. Credit: David Doubilet

(Medical Xpress) -- Sea anemones use venomous stinging tentacles to stun their prey, but one component of that venom is being used by researchers to treat the debilitating effects of Multiple Sclerosis (MS).

A new class of drug treatment is about to commence clinical trials, as the result of a decade-long investigation by Professor Ray Norton, from the Monash Institute of and his collaborators, who in the mid 1990s found a component of venom called ShK in the Caribbean .

The researchers found ShK blocks the Kv1.3 potassium channel located in , known as T-cells, which are known to produce in MS, one of the most common and debilitating diseases of the nervous system.

Professor Norton has since collaborated with a team of scientists in the United States investigating potassium channels as targets for the development of novel immunosuppressive agents.

With potassium channels controlling all sorts of key functions in the human body, developing a drug without unwanted side effects would have been impossible had it not turned out that the Kv1.3 potassium channel is found only on T-cells and in the nose. Because of this limited distribution, the researchers were able to develop a highly selective immune suppressant derived from the sea anemone peptide.

Professor Norton said that by blocking the , ShK prevented the T-cells from attacking the nervous system and causing the paralysis observed in .

"This research shows that we may be able to effectively treat the disease while protecting the immune system," Professor Norton said.

“Continuously blocking these T-cell channels with ShK should prevent further nerve damage, even after the initial onset of symptoms, including paralysis. If the clinical trials are successful, this could prove an effective treatment for MS.”

Professor Norton said ShK is one of the most potent inhibitors known for these channels.

“The next step is to find out what dose works best to treat MS and at what stage of the disease treatment should begin," Professor Norton said.

A close relative of corals and jellyfish, sea anemones spend most of their time attached to rocks on the sea floor or on coral reefs waiting for crustaceans and small fish to pass close enough to get entangled in their venom-filled tentacles.

Provided by Monash University search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Magnetic field and repulsion bewteen wires
    created3 hours ago
  • Enthalpy of reaction
    created9 hours ago
  • Harmonic oscillation problem -Dancing pot
    created10 hours ago
  • Ultracapacitor to power electromagnet?
    created10 hours ago
  • Confusion in Electro Statics
    created11 hours ago
  • simple gravity question
    created12 hours ago
  • More from Physics Forums - Classical Physics

More news stories

Vitamin D could provide new and effective treatments for asthma

(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...

Immunology created 10 hours ago | popularity not rated yet | comments 0 | with audio podcast

Immune protein could stop diabetes in its tracks

Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.

Immunology created 11 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Stem-cell-based strategy boosts immune system in mice

Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, ...

Immunology created May 16, 2013 | popularity 4.8 / 5 (5) | comments 0 | with audio podcast

Resistance to visceral leishmaniasis: New mechanisms involved

Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 ...

Immunology created May 16, 2013 | popularity not rated yet | comments 0

Women's immune systems remain younger for longer

Women's immune systems age more slowly than men's, suggests research in BioMed Central's open access journal Immunity & Ageing. The slower decline in a woman's immune system may contribute to women living longer than men. ...

Immunology created May 14, 2013 | popularity not rated yet | comments 0


Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Practice makes perfect? Not so much

Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...

Older prostate cancer patients should think twice before undergoing treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...

New test better detects elephantiasis worm infection

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...

Leading researchers report on the elusive search for biomarkers in Huntington's disease

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends ...

Vermont becomes third US state to legalize assisted suicide

Vermont became on Monday the third US state to legalize physician-assisted suicide.